According to Agios Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 55,803,663. At the end of 2023 the company had 55,803,663 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 55.8 M | 1.75% |
2022 | 54.84 M | 0.94% |
2021 | 54.33 M | -21.56% |
2020 | 69.27 M | 8.32% |
2019 | 63.94 M | 9.9% |
2018 | 58.18 M | 19.31% |
2017 | 48.77 M | 15.82% |
2016 | 42.11 M | 11.82% |
2015 | 37.66 M | 7.23% |
2014 | 35.12 M | 12.74% |
2013 | 31.15 M | 33.19% |
2012 | 23.38 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Pfizer PFE | 5,647,000,000 | 10,019.41% | ๐บ๐ธ USA |
Eli Lilly LLY | 949,379,000 | 1,601.28% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | 2,034,500,000 | 3,545.82% | ๐ฌ๐ง UK |
Xencor XNCR | 60,621,534 | 8.63% | ๐บ๐ธ USA |
Exelixis EXEL | 300,757,000 | 438.96% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | 188,866,000 | 238.45% | ๐บ๐ธ USA |